Latest News

BARDA grant awarded to Immunexpress to support development of Septicyte test for Sepsis Diagnosis

World’s first study of digital follow-up of patients treated with immune-checkpoint inhibitors uses Kaiku Health.

Debiopharm International working with Kaiku Health for digital patient monitoring in prostate cancer

Debiopharm Innovation Fund’s portfolio company BC Platforms to create a Health Data Discovery Platform for the UK’s National Biobank Network

Kaiku Health raises €4.4 million series A financing to accelerate its digital therapeutics pipeline led by Debiopharm and Tesi

BC Platforms Closes USD $10 million Series B Financing led by Debiopharm and Tesi to accelerate knowledge platform development

Debiopharm Innovation Fund: the New Name and Investment Strategy of Debiopharm Diagnostics

Debiopharm Strategic Fund announces FDA clearance of Portfolio Company Immunexpress’ first Test

Debiopharm invests double digit millions in the Canadian startup GenePOC, specialized in the development of rapid diagnostic tests